News

Cinryze is a purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor product for intravenous use. The company anticipates completion of labeling for previously produced vials to take approximately

The vitamins and supplements product line, which is marketed under the name Eternal Nutraceuticals, is comprised of 10 different products including Coenzyme Q10, eicosapentaenoic acid, docosahexaenoic acid, ginkgo

The co-primary clinical endpoints, change in cognitive and functional performance compared to placebo, were not met in Study 301, aPhase 3 trial of IV bapineuzumab in patients with

The facility enlargements and resulting jobs increase will generate an estimated $21 million per year in additional payroll and other benefits to local economies, according to the company.

NBTXR3, a nanoparticle formulation of hafnium oxide crystals, is designed for the local treatment of tumors. Under the agreement, Nanobiotix will receive an upfront payment of $1m and

All products will contain ProBiora3, the Company’s patented proprietary blend of three probiotics purposely designed for oral health. Oragenics president and CEO John Bonfiglio said the agreement reinforces

The launch of the Montelukast Sodium Tablets indicated for treating symptoms of asthma and allergic rhinitis follows the expiration of the last patent that provides Merck US market

The company expects to transfer research functions at Urogenix to Astellas’ Tsukuba Research Center in Japan. The closure of the North Carolina-based urology research facility, which at present

The patients in the SWOG S1106 mantle cell lymphoma trial will undergo testing for MRD during treatment and for up to three years of clinical follow up using